Sakurasaku Plus
7097
Timee
215A
Wintest
6721
Heartseed
219A
Raksul
4384
JP Stock MarketDetailed Quotes
4563 AnGes
- 51
- 00.00%
20min DelayMarket Closed Dec 13 15:30 JST
13.92BMarket Cap-1.30P/E (Static)
53High51Low2.39MVolume53Open51Pre Close124.30MTurnover9852wk High0.92%Turnover Ratio272.88MShares4352wk Low-45.9EPS TTM13.31BFloat Cap5596Historical HighLossP/E (Static)261.07MShs Float43Historical Low-39.29EPS LYR3.92%Amplitude--Dividend TTM0.48P/B100Lot Size--Div YieldTTM
About AnGes Company
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.
Company Profile
Symbol4563
Company NameAnGes
Founded1999-12-17
MarketTSE Growth
Employees62
Fiscal Year Ends12-31
Address7-7-15, Saito-asagi 4F, Saito Bio-Incubator
Zip Code108-0014
Phone---
Websitewww.anges.co.jp
Company Executives
- Name
- Position
- Salary
- Ei Yamada
- Representative Director , President and Chief Executive Officer
- --
- Shoya Satou
- Director
- --
- Norikazu Eiki
- Independent Director
- --
- Makoto Hara
- Independent Director
- --
- Kimiko Murofushi
- Independent Director
- --
- Junichi Komamura
- Independent Director
- --